Five commercially-available antibodies react differentially with allelic forms of human HLA-DR beta chain.

MLA

Houtman, Miranda, et al. “Five Commercially-Available Antibodies React Differentially with Allelic Forms of Human HLA-DR Beta Chain.” Molecular Immunology, vol. 152, Dec. 2022, pp. 106–10. EBSCOhost, https://doi.org/10.1016/j.molimm.2022.10.008.

APA

Houtman, M., Dzebisashvili, A., Dubnovitsky, A., Kozhukh, G., Rönnblom, L., Klareskog, L., Malmström, V., & Padyukov, L. (2022). Five commercially-available antibodies react differentially with allelic forms of human HLA-DR beta chain. Molecular Immunology, 152, 106–110. https://doi.org/10.1016/j.molimm.2022.10.008

Chicago

Houtman, Miranda, Anna Dzebisashvili, Anatoly Dubnovitsky, Genadiy Kozhukh, Lars Rönnblom, Lars Klareskog, Vivianne Malmström, and Leonid Padyukov. 2022. “Five Commercially-Available Antibodies React Differentially with Allelic Forms of Human HLA-DR Beta Chain.” Molecular Immunology 152 (December): 106–10. doi:10.1016/j.molimm.2022.10.008.